Drug Database · Clinicians

Diclofenac + Levomenthol + Linum usitatissimum seed + Methyl salicylate

Brands (2) Diclomet, Dition-PlusShow all

Non-steroidal anti-inflammatory drug (NSAID) PH FDA category
Fixed-dose combination.

Rx · Prescription drug2 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: For relief of the signs and symptoms of osteoarthritis US FDA label

    Kidney dosing: Diclofenac (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Usual dose by indication: osteoarthritis 100 to 150 mg/day, rheumatoid arthritis 150 to 200 mg/day, in divided doses (label). Lowest effective dose, shortest duration.
    CrCl 30–59 mL/min
    No dose change (pharmacokinetics unchanged; label). Kidney impairment raises the risk of NSAID kidney injury: monitor creatinine, potassium and blood pressure; avoid volume depletion and the ACE inhibitor or ARB plus diuretic combination.
    CrCl 15–29 mL/min
    No information from controlled studies in advanced kidney disease; avoid unless benefits outweigh the risk of worsening kidney function, and if used monitor kidney function (label, Renal Toxicity). Pharmacokinetics are unchanged in kidney impairment (inulin clearance down to <30 mL/min), so the risk is kidney injury, not accumulation.
    CrCl <15 mL/min (not on dialysis)
    No information from controlled studies in advanced kidney disease; avoid unless benefits outweigh the risk of worsening kidney function, and if used monitor kidney function (label, Renal Toxicity). Pharmacokinetics are unchanged in kidney impairment (inulin clearance down to <30 mL/min), so the risk is kidney injury, not accumulation.
    Hemodialysis (intermittent)
    Avoid unless benefits outweigh the risk (advanced kidney disease; label). Not removed by dialysis (over 99% protein-bound). NSAIDs may hasten loss of residual kidney function.
    Peritoneal dialysis
    Avoid unless benefits outweigh the risk (label). NSAIDs may hasten loss of residual kidney function.
    CRRT
    Avoid: NSAIDs can worsen acute kidney injury.
    • Dialyzable? Unlikely: hemodialysis may not be useful because of high protein binding (over 99%; label).
    • Monitoring Creatinine, potassium and blood pressure in CKD, heart failure, liver disease, dehydration or with ACE inhibitors, ARBs or diuretics. Liver enzymes within 4 to 8 weeks of starting long-term use (diclofenac hepatotoxicity warning).

    From the Diclofenac monograph (renalcarematters.com, reviewed).

  • levomenthol no separate page
  • linum usitatissimum seed no separate page
  • Use: Uses For the temporary relief of minor aches and pains of muscles and joints associated with: simple backache arthritis strains bruises sprains US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Topical gel: 0.369 g (1.16 % w/w)/3.150 g (10 % w/w)/1.575 g (5 % w/w)/0.318 g (1 % w/w) per 30 g, 0.369 g/3.150 g/1.575 g/0.318 g (1.16 %/10 %/5 %/1 % w/w) per 30 g

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Diclofenac + Levomenthol + Linum usitatissimum seed + Methyl salicylate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Diclofenac + Levomenthol + Linum usitatissimum seed + Methyl salicylate
Package insert
DiclometDiclofenac (as diethylamine) + Methyl Salicylate + Levomenthol +Linum usitatissimum (Linseed) Seed
0.369g (1.16% w/w) / 3.150g (10% w/w) / 1.575g (5% w/w) / 0.318g (1% w/w) per 30g Topical Gel30 g in Lami Tube (Box of 1's)
Rx
S Kant Healthcare Ltd.India
Biocare Lifesciences, Inc.
DRP-12520
Aug 26, 2027
Dition-PlusDiclofenac (as Diethylamine) + Methyl Salicylate + Levomenthol + Linum usitatissimum (Linseed) Seed
0.369g / 3.150 g / 1.575 g / 0.318g (1.16% / 10% / 5% / 1% w/w) per 30g Topical GelLaminated Tube with Peel-off Seal x 30g (Box of 1’s)
Rx
S Kant Healthcare LimitedIndia
Suhitas Pharmaceuticals Inc.
DRP-11475
Mar 15, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .